FRM
NUS icon

Fore Research & Management’s Nu Skin NUS Stock Holding History

Fore Research & Management’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-750
Closed -$33K – 75
2014
Q3 		$33K Buy
+750
New +$39.9K ﹤0.01% 78

Other funds holding NUS

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
VVP
Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Fore Research & Management's NUS Position: Q4 2014 in Review

Fore Research & Management sold out of Nu Skin (NUS) in Q4 2014, closing a stake of 750 shares — an estimated $33K sold.

Fore Research & Management first reported a position in NUS in Q3 2014 and held it in 1 quarter. The position peaked at $33K in Q3 2014. 211 funds tracked by Wall St. Rank hold NUS as of Q4 2014.

  • Fore Research & Management reported no remaining Nu Skin position as of Q4 2014 after selling out during the quarter.
  • Fore Research & Management sold 750 Nu Skin shares in Q4 2014, an estimated $33K.
  • Fore Research & Management first reported a position in Nu Skin in Q3 2014 and held it in 1 quarter.
  • Fore Research & Management's Nu Skin position peaked at $33K in Q3 2014.
  • 211 funds tracked by Wall St. Rank held Nu Skin as of Q4 2014.

Based on Fore Research & Management's 13F filing for Q4 2014, filed 11 Feb 2015.